| P3 Nutritionals,llc | |
|
1000 White Horse Rd Suite 902 Voorhees NJ 08043-4406 | |
| (609) 330-9391 | |
| Not Available |
| Full Name | P3 Nutritionals,llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1000 White Horse Rd, Voorhees, New Jersey |
| Authorized Official Name and Position | Robin B. Pacitti (OWNER) |
| Authorized Official Contact | 6093309391 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| P3 Nutritionals,llc Po Box 433 Haddonfield NJ 08033-0319 Ph: (609) 330-9391 | P3 Nutritionals,llc 1000 White Horse Rd Suite 902 Voorhees NJ 08043-4406 Ph: (609) 330-9391 |
| NPI Number | 1336378728 |
|---|---|
| Provider Enumeration Date | 07/07/2009 |
| Last Update Date | 07/07/2009 |
| Medicare PECOS PAC ID | 3870764152 |
|---|---|
| Medicare Enrollment ID | O20110916000226 |
News Archive
HealthSouth Rehabilitation Hospital of Round Rock, previously Reliant Rehabilitation Hospital Central Texas, is currently notifying potentially affected individuals that a laptop containing unsecured protected health information was stolen from the trunk of an employee's vehicle on or around Oct. 21, 2015.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
MAP Pharmaceuticals, Inc. announced today that it will present analysis of data from the efficacy portion of the first Phase 3 trial of its novel LEVADEX orally inhaled migraine therapy, currently in development, at the 14th Congress of the International Headache Society.
LifeVantage Corporation, has been granted a third patent for its flagship product Protandim from the United States Patent and Trademark Office. Protandim has been clinically proven in earlier studies to slow the progressive rate of aging by reducing oxidative stress and this new patent further documents Protandim's® effect on antioxidant enzymes in vivo, describing anti-inflammatory effects such as the lowering of C-reactive protein.
Recent initiatives in global health have made significant advances in knowledge, prevention and reduction of diseases affecting children in low-income countries.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336378728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Robin Beth Pacitti |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1871737551 PECOS PAC ID: 4789855065 Enrollment ID: I20110916000239 |
News Archive
HealthSouth Rehabilitation Hospital of Round Rock, previously Reliant Rehabilitation Hospital Central Texas, is currently notifying potentially affected individuals that a laptop containing unsecured protected health information was stolen from the trunk of an employee's vehicle on or around Oct. 21, 2015.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
MAP Pharmaceuticals, Inc. announced today that it will present analysis of data from the efficacy portion of the first Phase 3 trial of its novel LEVADEX orally inhaled migraine therapy, currently in development, at the 14th Congress of the International Headache Society.
LifeVantage Corporation, has been granted a third patent for its flagship product Protandim from the United States Patent and Trademark Office. Protandim has been clinically proven in earlier studies to slow the progressive rate of aging by reducing oxidative stress and this new patent further documents Protandim's® effect on antioxidant enzymes in vivo, describing anti-inflammatory effects such as the lowering of C-reactive protein.
Recent initiatives in global health have made significant advances in knowledge, prevention and reduction of diseases affecting children in low-income countries.
› Verified 4 days ago
News Archive
HealthSouth Rehabilitation Hospital of Round Rock, previously Reliant Rehabilitation Hospital Central Texas, is currently notifying potentially affected individuals that a laptop containing unsecured protected health information was stolen from the trunk of an employee's vehicle on or around Oct. 21, 2015.
Resverlogix Corp. announced today that results from the Company's Phase 1b/2a clinical trial have met and exceeded expectations by successfully concluding the drug, RVX-208, is safe and tolerable. Most importantly RVX-208 has met its primary endpoint to increase the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL), often referred to as "good" cholesterol.
MAP Pharmaceuticals, Inc. announced today that it will present analysis of data from the efficacy portion of the first Phase 3 trial of its novel LEVADEX orally inhaled migraine therapy, currently in development, at the 14th Congress of the International Headache Society.
LifeVantage Corporation, has been granted a third patent for its flagship product Protandim from the United States Patent and Trademark Office. Protandim has been clinically proven in earlier studies to slow the progressive rate of aging by reducing oxidative stress and this new patent further documents Protandim's® effect on antioxidant enzymes in vivo, describing anti-inflammatory effects such as the lowering of C-reactive protein.
Recent initiatives in global health have made significant advances in knowledge, prevention and reduction of diseases affecting children in low-income countries.
› Verified 4 days ago
Michael L. Marone, M. D. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 707 White Horse Rd, Suite C105, Voorhees, NJ 08043 Phone: 856-309-9700 Fax: 856-309-9192 | |
Momentum Medicine Plus Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 113 White Horse Rd W, Suite 7, Voorhees, NJ 08043 Phone: 856-552-2208 | |
Ally Housecall Physicians, P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 58 Downing Ln, Voorhees, NJ 08043 Phone: 609-367-6436 Fax: 856-874-9399 | |
Alta Dermatology & Skin Care Center, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 701 Cooper Rd, Suite #13, Voorhees, NJ 08043 Phone: 856-344-2849 Fax: 856-344-2938 | |
David Zweiback Do Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2301 E Evesham Rd, Voorhees, NJ 08043 Phone: 856-446-5600 | |
Winfield Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2301 E Evesham Rd, Suite 102, Voorhees, NJ 08043 Phone: 856-770-8204 Fax: 856-770-8207 | |
Associates In Primary Care, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2301 E Evesham Rd, 305, Voorhees, NJ 08043 Phone: 856-772-4353 Fax: 856-772-4359 |